Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Amortization of Deferred Charges (2010 - 2026)

Updated

Tg Therapeutics' Amortization of Deferred Charges came in at $53,000 for Q2 2021, down 5.4% from $56,000 a year earlier and unchanged from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2021, Tg Therapeutics reported Amortization of Deferred Charges of $212,000, up 5.5% year-over-year; for FY2020, it was $216,000, up 18.7% from FY2019.

  • Amortization of Deferred Charges has increased in each of the last three years, with a three-year compound annual growth rate of 20.0% (FY2017 to FY2020).
  • Going back by year, Amortization of Deferred Charges was $182,000 in FY2019 (+34.8%), $135,000 in FY2018 (+8.0%) and $125,000 in FY2017.
  • The five-year range for quarterly Amortization of Deferred Charges is $37,000 (Q4 2018) to $56,000 (Q2 2020).
  • Year-over-year, Amortization of Deferred Charges increased in five of the last seven quarters, with growth averaging 12.7%.
  • Business Quant data shows TGTX's Amortization of Deferred Charges at $53,000 (Q1 2021), $53,000 (Q4 2020) and $53,000 (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 247,000.00
Jun 30, 2026 232,000.00
Mar 31, 2026 300,000.00
Dec 31, 2025 304,000.00
Sep 30, 2025 304,000.00
Jun 30, 2025 304,000.00
Mar 31, 2025 304,000.00
Dec 31, 2024 308,000.00
Sep 30, 2024 414,000.00
Jun 30, 2024 639,000.00
Mar 31, 2024 639,000.00
Dec 31, 2023 661,000.00
Sep 30, 2023 639,000.00
Jun 30, 2023 639,000.00
Mar 31, 2023 461,000.00
Dec 31, 2022 461,000.00
Sep 30, 2022 461,000.00
Jun 30, 2022 461,000.00
Mar 31, 2022 461,000.00
Dec 31, 2021 386,000.00
API Access

Tg Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=TGTX&period=max&api_key=YOUR_API_KEY